Revolution Medicines Inc. Common Stock vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.69 (market cap $40.32B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $42.17 (market cap $3.80B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 10.6× Vanguard Global ex-US Real Estate Index Fd ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Vanguard Global ex-US Real Estate Index Fd ETF for 95 Days on average.
| RVMD | VNQI | |
|---|---|---|
Market Cap | $40.32B | $3.80B |
Volume | 4,855,734 | 277,049 |
Sector | Health | — |
52-Week High | $221.15 | $50.76 |
52-Week Low | $47.50 | $41.81 |
Typical Hold Time | 0 Days | 95 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VNQI (Vanguard Global ex-U.S. Real Estate ETF) trades at $42.08, up 0.63% with bearish technical signals from moving averages. The ETF provides international real estate exposure across 30+ countries, offering a higher dividend yield than domestic alternatives. Recent news highlights a significant 45.9% drop in short interest in September 2026, while technical indicators show oversold conditions with RSI readings below 30.
The ETF faces headwinds from global real estate market volatility but offers diversification benefits and income potential. Key risks include international currency exposure and regional economic uncertainties. The substantial decline in short interest suggests potential sentiment improvement, though technical trends remain bearish near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).
Read more on VNQI →